Format

Send to

Choose Destination
See comment in PubMed Commons below
Drug Des Devel Ther. 2013 Nov 12;7:1341-57. doi: 10.2147/DDDT.S40107. eCollection 2013.

Animal models of ulcerative colitis and their application in drug research.

Author information

1
Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Abstract

The specific pathogenesis underlying inflammatory bowel disease is complex, and it is even more difficult to decipher the pathophysiology to explain for the similarities and differences between two of its major subtypes, Crohn's disease and ulcerative colitis (UC). Animal models are indispensable to pry into mechanistic details that will facilitate better preclinical drug/therapy design to target specific components involved in the disease pathogenesis. This review focuses on common animal models that are particularly useful for the study of UC and its therapeutic strategy. Recent reports of the latest compounds, therapeutic strategies, and approaches tested on UC animal models are also discussed.

KEYWORDS:

emerging therapy; inflammatory bowel disease; preclinical trials

PMID:
24250223
PMCID:
PMC3829622
DOI:
10.2147/DDDT.S40107
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Support Center